Search Results
Search results for "Nobel Prize"
Results found for "Nobel Prize"
- Scott Struthers | Dr. GPCR Ecosystem
chair at Radionetics Oncology, a pharmaceutical company focused on the discovery and development of novel
- Dr. Hannes Schihada | Dr. GPCR Ecosystem
I spent 2 1/2 years in his lab and developed novel conformational sensors for these intriguing receptors
- Dr. Graeme Milligan | Dr. GPCR Ecosystem
Milligan is the co-founder of both Caldan Therapeutics (2015) which discovers novel therapeutics for
- Dr. Nicola J. Smith | Dr. GPCR Ecosystem
Together with Irina Kufareva , UCSD, her team developed a novel approach to identifying ligands for orphan
- Dr. Aylin Hanyaloglu | Dr. GPCR Ecosystem
at the University of California, San Francisco with Professor Mark von Zastrow where she identified novel
- Dr. Andrew Tobin | Dr. GPCR Ecosystem
at the University of Glasgow, his primary research interests are focused on the rational design of novel
- Dr. Khaled Abdelrahman | Dr. GPCR Ecosystem
Molecular Medicine and Neuroscience at the University of Ottawa as a Postdoctoral Fellow to explore novel
- Dr. Nicholas Holliday | Dr. GPCR Ecosystem
establishing a lab focused on G protein-coupled receptor kinetics, signaling, and trafficking and on using novel
- Dr. Adriano Marchese | Dr. GPCR Ecosystem
The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic
- Dr. Tobi Langenhan | Dr. GPCR Ecosystem
cellular and organ functions, which require individual adhesion GPCRs, and extends to the development of novel
- Aaron Sato: Synthetic Antibody Libraries for the Hardest GPCR Targets | Dr. GPCR Ecosystem
Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class technology to manufacture DNA at a scale, the team saw an opportunity to tackle the challenge of identifying novel
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
There, I completed a PhD in biochemistry exploring the non-canonical functions and possible novel mechanisms the impact of GPCR ubiquitination on signaling and β-arrestin functions, and the characterization of novel
- Dr. Katarina Nemec | Dr. GPCR Ecosystem
used for functional screens with state-of-the-art microscopy and high throughput screening to explain novel
- Dr. Sudarshan Rajagopal | Dr. GPCR Ecosystem
His lab is also interested in identifying novel signal transduction mechanisms of GPCRs, such as the
- Anything BUT GPCRs with Dr. Mikel Garcia-Marcos | Dr. GPCR Ecosystem
systems (purified proteins, cultured cells, model organisms) in combination with the development of novel
- Dr. JoAnn Trejo | Dr. GPCR Ecosystem
recognized expert on protease-activated receptors, particularly PAR1, and over the years she has discovered novel
- Signals, pH, and Discovery : Cracking GPCR Mysteries with Dr. Ian Chronis | Dr. GPCR Ecosystem
trafficking and signaling of adrenergic and proton-sensing receptors, with specific focus on identifying novel
- Dr. Gregory Tall | Dr. GPCR Ecosystem
Tall moved upstairs to conduct his postdoctoral work on heterotrimeric G proteins and the novel interactor
- The Scientist's Compass: From Academia to Entrepreneurship with Dr. Dmitry Veprintsev | Dr. GPCR Ecosystem
Interdisciplinary Research & Future Directions – Exploring combinatorial drug actions, receptor interactions, and novel
- David Gloriam: Orphan Receptors, GPCRDB, and the Data Revolution in GPCR Pharmacology | Dr. GPCR Ecosystem
structural pharmacology through the work of David Gloriam, whose career spans the identification of 26 novel his Ph.D. from Uppsala University in Sweden where he worked on the bioinformatic identification of 24 novel
- How Lipid Rafts Organize GPCR Signaling | Dr. GPCR Ecosystem
efficacy and diagnostic innovation What the functional diversity of bitter taste receptors means for novel
- Re-cap of Endocrine Metabolic GPCR 2024 with the Organizers | Dr. GPCR Ecosystem
at the University of California, San Francisco with Professor Mark von Zastrow where she identified novel
- GPCR Assay Strategy, Bias, and Translational Drug Discovery | Dr. GPCR Ecosystem
the challenge of translating in vitro pharmacology to in vivo models, lessons on bias agonism, and novel
- Why Mosquitoes Hunt You: GPCR Control of Blood Feeding and Mating | Dr. GPCR Ecosystem
If you are considering novel ways to connect molecular pharmacology with organismal phenotype, especially
- Model. Predict. Discover. with Dr. Jens Carlsson | Dr. GPCR Ecosystem
believes modeling should predict , not just explain How his team uses structure-based modeling to identify novel
- Fluorescent Probes for GLP-1R and GIPR Imaging: From Cell Assays to In Vivo Systems | Dr. GPCR Ecosystem
His research group develops and applies novel technologies to investigate GLP-1 and GIP receptors — two
- Tore Bengtsson: Rethinking β₂-Adrenergic Signaling in Metabolic Disease | Dr. GPCR Ecosystem
His work focuses on developing novel β₂-adrenergic ligands that selectively engage signaling pathways That’s what we’ve now achieved with new compounds that stimulate the receptor in a novel way.
- Eurofins Discovery GPCR Solutions | Drug Discovery & Development Partner | Dr. GPCR
Custom Assays & Deorphanization Custom assay development and deorphanization for challenging or novel
- University Pricing | Dr. GPCR Ecosystem
Jobs Board Complete GPCR Coverage Community Tools Career Matchmaker Frequently Asked Questions Premium Pricing
- Dr. GPCR Team | Dr. GPCR Ecosystem
Further down the track, he aims to apply this knowledge to develop novel chemical treatments for neuronal




























